Zhang, Li-Sheng http://orcid.org/0000-0003-1872-9978
Ye, Chang http://orcid.org/0000-0003-0236-5671
Ju, Cheng-Wei http://orcid.org/0000-0002-2250-8548
Gao, Boyang http://orcid.org/0000-0002-6956-1450
Feng, Xinran http://orcid.org/0000-0002-6106-8645
Sun, Hui-Lung
Wei, Jiangbo http://orcid.org/0000-0003-2691-6490
Yang, Fan
Dai, Qing http://orcid.org/0000-0002-8578-1568
He, Chuan http://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RM1 HG008935)
Article History
Received: 4 January 2023
Accepted: 25 September 2023
First Online: 15 November 2023
Competing interests
: A patent application for BID-seq has been filed by The University of Chicago. C.H. is a scientific founder, member of the scientific advisory board and equity holder of Aferna Bio, Inc. and AccuaDX Inc.; a scientific cofounder and equity holder of Accent Therapeutics, Inc.; and a member of the scientific advisory board of Rona Therapeutics.